Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NOTCH-Induced MDSC Recruitment after oHSV Virotherapy in CNS Cancer Models Modulates Antitumor Immunotherapy
Yoshihiro Otani, Ji Young Yoo, Cole T. Lewis, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 7, pp. 1460-1473
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Therapy with oncolytic viruses: progress and challenges
Sophia Z. Shalhout, David M. Miller, Kevin S. Emerick, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 3, pp. 160-177
Closed Access | Times Cited: 290
The Notch signaling pathway: a potential target for cancer immunotherapy
Xinxin Li, Xianchun Yan, Yufeng Wang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 85
A Dual‐Responsive STAT3 Inhibitor Nanoprodrug Combined with Oncolytic Virus Elicits Synergistic Antitumor Immune Responses by Igniting Pyroptosis
Wen Su, Wei Qiu, Shu‐Jin Li, et al.
Advanced Materials (2022) Vol. 35, Iss. 11
Closed Access | Times Cited: 72
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
Hao Lin, Chaxian Liu, An-Kang Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 66
Macrophages in Recurrent Glioblastoma as a Prognostic Factor in the Synergistic System of the Tumor Microenvironment
Nicola Montemurro, Bhavya Pahwa, Anish Tayal, et al.
Neurology International (2023) Vol. 15, Iss. 2, pp. 595-608
Open Access | Times Cited: 43
Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation
Haonan Li, Qiang Luo, Hu Zhang, et al.
Chemical Society Reviews (2022) Vol. 52, Iss. 1, pp. 47-96
Closed Access | Times Cited: 47
Novel insights into Notch signaling in tumor immunity: potential targets for cancer immunotherapy
Man Wang, Fei Yu, Yuan Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Crosstalk of pyroptosis and cytokine in the tumor microenvironment: from mechanisms to clinical implication
Hua Wang, Tao Wang, Shuxiang Yan, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Rat and Mouse Brain Tumor Models for Experimental Neuro-Oncology Research
Upasana Sahu, Rolf F. Barth, Yoshihiro Otani, et al.
Journal of Neuropathology & Experimental Neurology (2022) Vol. 81, Iss. 5, pp. 312-329
Open Access | Times Cited: 31
The Glioma Immune Landscape: A Double-Edged Sword for Treatment Regimens
Sukrit Mahajan, Mirko H. H. Schmidt, Ulrike Schumann
Cancers (2023) Vol. 15, Iss. 7, pp. 2024-2024
Open Access | Times Cited: 17
Targeting tumor-associated macrophages: Novel insights into immunotherapy of skin cancer
Jun Liu, Jiaye Lu, Ling Wu, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 5
Immune landscape and response to oncolytic virus-based immunotherapy
Chaolong Lin, Wenzhong Teng, Tian Yang, et al.
Frontiers of Medicine (2024) Vol. 18, Iss. 3, pp. 411-429
Closed Access | Times Cited: 5
Oncolytic virus therapy for malignant gliomas: entering the new era
Hirotaka Fudaba, Hiroaki Wakimoto
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 3, pp. 269-282
Closed Access | Times Cited: 12
Potential targeting of the tumor microenvironment to improve cancer virotherapy
Zi‐Xian Liao, Shan‐hui Hsu, Shiue–Cheng Tang, et al.
Pharmacology & Therapeutics (2023) Vol. 250, pp. 108521-108521
Closed Access | Times Cited: 11
MDSCs in bone metastasis: Mechanisms and therapeutic potential
Zhi Li, Qi Xia, Yujie He, et al.
Cancer Letters (2024) Vol. 592, pp. 216906-216906
Closed Access | Times Cited: 4
Gene Therapy for High Grade Glioma: The Clinical Experience
María L. Varela, Andrea Comba, Syed Mohd Faisal, et al.
Expert Opinion on Biological Therapy (2022) Vol. 23, Iss. 2, pp. 145-161
Open Access | Times Cited: 18
The Recruitment and Immune Suppression Mechanisms of Myeloid‐Derived Suppressor Cells and Their Impact on Bone Metastatic Cancer
Chengyuan Li, Yucheng Xue, Eloy Yinwang, et al.
Cancer Reports (2025) Vol. 8, Iss. 2
Open Access
Immunosuppressive cells in oncolytic virotherapy for glioma: challenges and solutions
Junfeng Liu, Raziye Piranlioglu, Fei Ye, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 8
IFI35 limits antitumor immunity in triple-negative breast cancer via CCL2 secretion
Baojin Xu, Hefen Sun, Simeng Liu, et al.
Oncogene (2024) Vol. 43, Iss. 10, pp. 693-702
Open Access | Times Cited: 3
Mediator complex subunit 1 promotes oral squamous cell carcinoma progression by activating MMP9 transcription and suppressing CD8+ T cell antitumor immunity
Zhe Li, Mengke Sun, Ruimeng Yang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 3
Implications of immune cells in oncolytic herpes simplex virotherapy for glioma
Yoshihiro Otani, Ji Young Yoo, Toshihiko Shimizu, et al.
Brain Tumor Pathology (2022) Vol. 39, Iss. 2, pp. 57-64
Open Access | Times Cited: 13
A recombinant oncolytic influenza virus expressing a PD-L1 antibody induces CD8+ T-cell activation via the cGas-STING pathway in mice with hepatocellular carcinoma
Fang Sun, Yan Xu, Zhuoya Deng, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110323-110323
Open Access | Times Cited: 8
Glioma stem cells remodel immunotolerant microenvironment in GBM and are associated with therapeutic advancements
Xifeng Fei, Jie Wu, Haiyan Tian, et al.
Cancer Biomarkers (2024) Vol. 41, Iss. 1, pp. 1-24
Closed Access | Times Cited: 2
Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9/ NOTCH/ DDR axis in pancreatic ductal adenocarcinoma
Qin-Yuan Jia, Yuheng Zhu, Hong-Fei Yao, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 10
Open Access | Times Cited: 2
Oncolytic virus-driven immune remodeling revealed in mouse medulloblastomas at single cell resolution
Jack Hedberg, Adam Studebaker, L.T. Smith, et al.
Molecular Therapy — Oncolytics (2023) Vol. 30, pp. 39-55
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top